TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs303084
log Bayes Factor = 5.86646
Chromosome 4   position 124,066,948  (GRCh37) Explore rs303084 on Ensembl!
Variant rs303084 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E11.9 Without complications
1.000 0.000 0.000
E11 Non-insulin-dependent diabetes mellitus
0.999 0.001 0.000
E11.3 With ophthalmic complications
0.957 0.043 0.000
E11.4 With neurological complications
0.923 0.077 0.000
E11.2 With renal complications
0.905 0.095 0.000
E10-E14 Diabetes mellitus
0.896 0.104 0.000
E11.1 With ketoacidosis
0.888 0.112 0.000
E10 Insulin-dependent diabetes mellitus
0.873 0.127 0.000
E10.1 With ketoacidosis
0.820 0.180 0.000
E11.6 With other specified complications
0.817 0.183 0.000
E10.4 With neurological complications
0.808 0.192 0.000
E11.7 With multiple complications
0.790 0.210 0.000
E10.5 With peripheral circulatory complications
0.737 0.263 0.000
E11.0 With coma
0.720 0.280 0.000
E13 Other specified diabetes mellitus
0.696 0.304 0.000
E10.6 With other specified complications
0.672 0.328 0.000
E11.8 With unspecified complications
0.671 0.328 0.000
E10.3 With ophthalmic complications
0.663 0.337 0.000
E10.0 With coma
0.654 0.346 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.644 0.356 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.643 0.357 0.000
E12 Malnutrition-related diabetes mellitus
0.642 0.357 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.632 0.368 0.000
E10.7 With multiple complications
0.630 0.369 0.000
E14 Unspecified diabetes mellitus
0.605 0.395 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.592 0.408 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.590 0.410 0.000
E10.8 With unspecified complications
0.583 0.417 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.565 0.435 0.000
T43.2 Other and unspecified antidepressants
0.558 0.442 0.000
E13.9 Without complications
0.558 0.442 0.000
T39.1 4-Aminophenol derivatives
0.554 0.446 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.534 0.466 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.523 0.477 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.520 0.480 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.518 0.482 0.000
T36 Poisoning by systemic antibiotics
0.501 0.499 0.000
E13.8 With unspecified complications
0.499 0.501 0.000
E13.7 With multiple complications
0.499 0.501 0.000
E13.6 With other specified complications
0.499 0.501 0.000
E13.5 With peripheral circulatory complications
0.499 0.501 0.000
E13.4 With neurological complications
0.499 0.501 0.000
E13.2 With renal complications
0.499 0.501 0.000
E13.1 With ketoacidosis
0.499 0.501 0.000
E13.0 With coma
0.499 0.501 0.000
T42.4 Benzodiazepines
0.497 0.503 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.497 0.503 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.497 0.503 0.000
E13.3 With ophthalmic complications
0.490 0.510 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.490 0.510 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.487 0.513 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.475 0.525 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.472 0.528 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.470 0.530 0.000
E14.4 With neurological complications
0.465 0.535 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.464 0.536 0.000
T43.9 Psychotropic drug, unspecified
0.462 0.537 0.000
E14.0 With coma
0.462 0.538 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.461 0.538 0.000
E12.9 Without complications
0.461 0.539 0.000
E12.8 With unspecified complications
0.461 0.539 0.000
E12.7 With multiple complications
0.461 0.539 0.000
E12.6 With other specified complications
0.461 0.539 0.000
E12.5 With peripheral circulatory complications
0.461 0.539 0.000
E12.4 With neurological complications
0.461 0.539 0.000
E12.3 With ophthalmic complications
0.461 0.539 0.000
E12.2 With renal complications
0.461 0.539 0.000
E12.1 With ketoacidosis
0.461 0.539 0.000
E12.0 With coma
0.461 0.539 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.460 0.540 0.000
T46.1 Calcium-channel blockers
0.453 0.547 0.000
E14.2 Withrenal complications
0.452 0.548 0.000
E14.1 With ketoacidosis
0.451 0.549 0.000
T40.2 Other opioids
0.451 0.549 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.449 0.550 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.447 0.553 0.000
E10.2 With renal complications
0.446 0.554 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.445 0.555 0.000
T43.6 Psychostimulants with abuse potential
0.444 0.556 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.442 0.558 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.442 0.558 0.000
E14.8 With unspecified complications
0.441 0.558 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.435 0.564 0.000
E14.7 With multiple complications
0.433 0.566 0.000
T39.4 Antirheumatics, not elsewhere classified
0.424 0.575 0.000
T39.2 Pyrazolone derivatives
0.424 0.575 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.423 0.576 0.000
T42.2 Succinimides and oxazolidinediones
0.423 0.576 0.000
E10.9 Without complications
0.422 0.578 0.000
E14.6 With other specified complications
0.420 0.580 0.000
T42.3 Barbiturates
0.414 0.586 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.412 0.587 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.412 0.588 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.411 0.589 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.409 0.591 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.406 0.594 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.405 0.594 0.000
T46.7 Peripheral vasodilators
0.405 0.594 0.000
E14.9 Without complications
0.403 0.597 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.400 0.600 0.000
T36.0 Penicillins
0.399 0.601 0.000
E14.5 With peripheral circulatory complications
0.395 0.605 0.000
T40.5 Cocaine
0.391 0.608 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.391 0.609 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.390 0.610 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.386 0.614 0.000
T42.1 Iminostilbenes
0.373 0.626 0.000
T39.0 Salicylates
0.363 0.637 0.000
T40.1 Heroin
0.362 0.638 0.000
T36.9 Systemic antibiotic, unspecified
0.359 0.641 0.000
T36.8 Other systemic antibiotics
0.359 0.641 0.000
T36.7 Antifungal antibiotics, systemically used
0.359 0.641 0.000
T36.6 Rifamycins
0.359 0.641 0.000
T36.5 Aminoglycosides
0.359 0.641 0.000
T36.2 Chloramphenicol group
0.359 0.641 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.356 0.643 0.000
T40.8 Lysergide [LSD]
0.356 0.643 0.000
T40.7 Cannabis (derivatives)
0.356 0.643 0.000
T40.0 Opium
0.356 0.643 0.000
T41.2 Other and unspecified general anaesthetics
0.354 0.646 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.351 0.649 0.000
T36.4 Tetracyclines
0.350 0.649 0.000
E14.3 With ophthalmic complications
0.347 0.653 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.343 0.657 0.000
T36.3 Macrolides
0.341 0.659 0.000
T45.2 Vitamins, not elsewhere classified
0.341 0.659 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.341 0.659 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.341 0.659 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.341 0.659 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.341 0.659 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.341 0.659 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.341 0.659 0.000
T44.0 Anticholinesterase agents
0.341 0.659 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.338 0.662 0.000
T41.5 Therapeutic gases
0.337 0.663 0.000
T41.4 Anaesthetic, unspecified
0.337 0.663 0.000
T41.3 Local anaesthetics
0.337 0.663 0.000
T41.1 Intravenous anaesthetics
0.337 0.663 0.000
T41.0 Inhaled anaesthetics
0.337 0.663 0.000
T40.3 Methadone
0.337 0.663 0.000
T40.6 Other and unspecified narcotics
0.335 0.665 0.000
T49.9 Topical agent, unspecified
0.332 0.667 0.000
T49.8 Other topical agents
0.332 0.667 0.000
T49.7 Dental drugs, topically applied
0.332 0.667 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.332 0.667 0.000
T49.5 Ophthalmological drugs and preparations
0.332 0.667 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.332 0.667 0.000
T49.3 Emollients, demulcents and protectants
0.332 0.667 0.000
T49.2 Local astringents and local detergents
0.332 0.667 0.000
T49.1 Antipruritics
0.332 0.667 0.000
T50.1 Loop [high-ceiling] diuretics
0.332 0.667 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.332 0.668 0.000
T47.0 Histamine H(2)-receptor antagonists
0.332 0.668 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.330 0.670 0.000
T37.5 Antiviral drugs
0.330 0.670 0.000
T37.4 Anthelminthics
0.330 0.670 0.000
T37.3 Other antiprotozoal drugs
0.330 0.670 0.000
T37.1 Antimycobacterial drugs
0.330 0.670 0.000
T37.0 Sulphonamides
0.330 0.670 0.000
E11.5 With peripheral circulatory complications
0.329 0.670 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.327 0.672 0.000
T47.4 Other laxatives
0.327 0.673 0.000
T50.8 Diagnostic agents
0.325 0.674 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.325 0.675 0.000
T42.0 Hydantoin derivatives
0.321 0.679 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.320 0.679 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.319 0.681 0.000
T48.4 Expectorants
0.319 0.681 0.000
T48.3 Antitussives
0.319 0.681 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.319 0.681 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.319 0.681 0.000
T48.0 Oxytocic drugs
0.319 0.681 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.319 0.681 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.317 0.683 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.317 0.683 0.000
T47.7 Emetics
0.317 0.683 0.000
T47.5 Digestants
0.317 0.683 0.000
T47.3 Saline and osmotic laxatives
0.317 0.683 0.000
T50.7 Analeptics and opioid receptor antagonists
0.312 0.688 0.000
T50.5 Appetite depressants
0.312 0.688 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.312 0.688 0.000
T50.0 Mineralocorticoids and their antagonists
0.312 0.688 0.000
T48.5 Anti-common-cold drugs
0.311 0.688 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.305 0.695 0.000
T47.6 Antidiarrhoeal drugs
0.304 0.695 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.303 0.697 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.302 0.698 0.000
T38.0 Glucocorticoids and synthetic analogues
0.302 0.698 0.000
T47.2 Stimulant laxatives
0.301 0.698 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.295 0.705 0.000
T45.8 Other primarily systemic and haematological agents
0.295 0.705 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.295 0.705 0.000
T45.6 Fibrinolysis-affecting drugs
0.295 0.705 0.000
T45.4 Iron and its compounds
0.295 0.705 0.000
T45.3 Enzymes, not elsewhere classified
0.295 0.705 0.000
T38.9 Other and unspecified hormone antagonists
0.293 0.706 0.000
T38.7 Androgens and anabolic congeners
0.293 0.706 0.000
T38.4 Oral contraceptives
0.293 0.706 0.000
T38.2 Antithyroid drugs
0.293 0.706 0.000
T50.4 Drugs affecting uric acid metabolism
0.288 0.712 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.286 0.714 0.000
T45.0 Antiallergic and antiemetic drugs
0.280 0.719 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.276 0.724 0.000
T38.5 Other oestrogens and progestogens
0.272 0.727 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.265 0.735 0.000
T38.1 Thyroid hormones and substitutes
0.262 0.738 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.247 0.753 0.000
T45.5 Anticoagulants
0.227 0.773 0.000
T40.4 Other synthetic narcotics
0.188 0.811 0.001
F31 Bipolar affective disorder
0.125 0.875 0.000
F30-F39 Mood [affective] disorders
0.114 0.886 0.000
F31.0 Bipolar affective disorder, current episode hypomanic
0.113 0.887 0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms
0.112 0.888 0.000
F33 Recurrent depressive disorder
0.110 0.890 0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms
0.107 0.893 0.000
F31.6 Bipolar affective disorder, current episode mixed
0.104 0.896 0.000
F31.9 Bipolar affective disorder, unspecified
0.104 0.896 0.000
F33.9 Recurrent depressive disorder, unspecified
0.103 0.897 0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression
0.101 0.899 0.000
F39 Unspecified mood [affective] disorder
0.100 0.899 0.000
F34 Persistent mood [affective] disorders
0.100 0.900 0.000
F31.8 Other bipolar affective disorders
0.100 0.900 0.000
F33.1 Recurrent depressive disorder, current episode moderate
0.100 0.900 0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms
0.094 0.906 0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms
0.088 0.912 0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.088 0.912 0.000
F34.1 Dysthymia
0.087 0.913 0.000
F38 Other mood [affective] disorders
0.085 0.915 0.000
F34.0 Cyclothymia
0.079 0.921 0.000
F31.7 Bipolar affective disorder, currently in remission
0.078 0.922 0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.077 0.923 0.000
F33.4 Recurrent depressive disorder, currently in remission
0.075 0.925 0.000
F33.0 Recurrent depressive disorder, current episode mild
0.074 0.926 0.000
F34.9 Persistent mood [affective] disorder, unspecified
0.072 0.928 0.000
F34.8 Other persistent mood [affective] disorders
0.072 0.928 0.000
F33.8 Other recurrent depressive disorders
0.064 0.936 0.000
F38.8 Other specified mood [affective] disorders
0.064 0.936 0.000
F32 Depressive episode
0.062 0.938 0.000
F38.0 Other single mood [affective] disorders
0.061 0.939 0.000
F38.1 Other recurrent mood [affective] disorders
0.061 0.939 0.000
F30 Manic episode
0.059 0.940 0.000
F32.0 Mild depressive episode
0.058 0.942 0.000
F32.1 Moderate depressive episode
0.050 0.950 0.000
F30.1 Mania without psychotic symptoms
0.048 0.951 0.000
F32.8 Other depressive episodes
0.043 0.957 0.000
F30.8 Other manic episodes
0.043 0.957 0.000
F30.2 Mania with psychotic symptoms
0.041 0.959 0.000
F30.0 Hypomania
0.036 0.964 0.000
F32.3 Severe depressive episode with psychotic symptoms
0.036 0.964 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.027 0.973 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.975 0.025
E20-E35 Disorders of other endocrine glands
0.025 0.975 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.978 0.022
E26 Hyperaldosteronism
0.022 0.978 0.000
Chapter V Mental and behavioural disorders
0.022 0.978 0.000
F30.9 Manic episode, unspecified
0.021 0.978 0.001
F60 Specific personality disorders
0.022 0.978 0.000
F60-F69 Disorders of adult personality and behaviour
0.022 0.978 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.021 0.978 0.000
E23 Hypofunction and other disorders of pituitary gland
0.021 0.979 0.000
E27 Other disorders of adrenal gland
0.021 0.979 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.979 0.021
E26.0 Primary hyperaldosteronism
0.021 0.979 0.000
E28 Ovarian dysfunction
0.020 0.980 0.000
F80-F89 Disorders of psychological development
0.020 0.980 0.000
C91 Lymphoid leukaemia
0.000 0.981 0.019
F32.2 Severe depressive episode without psychotic symptoms
0.019 0.981 0.000
E23.2 Diabetes insipidus
0.019 0.981 0.000
E32 Diseases of thymus
0.019 0.981 0.000
C85.1 B-cell lymphoma, unspecified
0.000 0.981 0.019
Z02.8 Other examinations for administrative purposes
0.000 0.981 0.019
E27.8 Other specified disorders of adrenal gland
0.019 0.981 0.000
F60.9 Personality disorder, unspecified
0.019 0.981 0.000
F60.3 Emotionally unstable personality disorder
0.018 0.982 0.000
E21.3 Hyperparathyroidism, unspecified
0.018 0.982 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.018 0.982 0.000
E30 Disorders of puberty, not elsewhere classified
0.018 0.982 0.000
E65-E68 Obesity and other hyperalimentation
0.018 0.982 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.018 0.982 0.000
F60.8 Other specific personality disorders
0.018 0.982 0.000
C95 Leukaemia of unspecified cell type
0.000 0.982 0.018
E31 Polyglandular dysfunction
0.018 0.982 0.000
F60.7 Dependent personality disorder
0.017 0.983 0.000
E26.9 Hyperaldosteronism, unspecified
0.017 0.983 0.000
E25 Adrenogenital disorders
0.017 0.983 0.000
F60.5 Anankastic personality disorder
0.017 0.983 0.000
E23.6 Other disorders of pituitary gland
0.017 0.983 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.017 0.983 0.000
F61 Mixed and other personality disorders
0.017 0.983 0.000
C86 Other specified types of T/NK-cell lymphoma
0.000 0.983 0.017
C91.1 Chronic lymphocytic leukaemia
0.000 0.983 0.017
C92 Myeloid leukaemia
0.000 0.983 0.017
F43 Reaction to severe stress, and adjustment disorders
0.017 0.983 0.000
C91.0 Acute lymphoblastic leukaemia
0.000 0.983 0.017
F60.2 Dissocial personality disorder
0.017 0.983 0.000
F40-F48 Neurotic, stress-related and somatoform disorders
0.017 0.983 0.000
C81 Hodgkin's disease
0.000 0.983 0.017
C91.9 Lymphoid leukaemia, unspecified
0.000 0.984 0.016
E28.3 Primary ovarian failure
0.016 0.984 0.000
L03.3 Cellulitis of trunk
0.000 0.984 0.016
E26.8 Other hyperaldosteronism
0.016 0.984 0.000
E26.1 Secondary hyperaldosteronism
0.016 0.984 0.000
C93 Monocytic leukaemia
0.000 0.984 0.016
F64 Gender identity disorders
0.016 0.984 0.000
F81 Specific developmental disorders of scholastic skills
0.016 0.984 0.000
C94 Other leukaemias of specified cell type
0.000 0.984 0.016
F84 Pervasive developmental disorders
0.016 0.984 0.000
C91.5 Adult T-cell leukaemia
0.000 0.984 0.016
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.984 0.016
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.984 0.016
F60.4 Histrionic personality disorder
0.016 0.984 0.000
E21.2 Other hyperparathyroidism
0.016 0.984 0.000
E40-E46 Malnutrition
0.016 0.984 0.000
C85.0 Lymphosarcoma
0.000 0.984 0.016
F70-F79 Mental retardation
0.016 0.984 0.000
F60.1 Schizoid personality disorder
0.016 0.984 0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation
0.016 0.984 0.000
F65 Disorders of sexual preference
0.016 0.984 0.000
F63 Habit and impulse disorders
0.016 0.984 0.000
F60.0 Paranoid personality disorder
0.016 0.984 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.016 0.984 0.000
F60.6 Anxious [avoidant] personality disorder
0.016 0.984 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.016 0.984 0.000
E21.4 Other specified disorders of parathyroid gland
0.015 0.984 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.015 0.984 0.000
E28.2 Polycystic ovarian syndrome
0.015 0.985 0.000
E23.1 Drug-induced hypopituitarism
0.015 0.985 0.000
E20 Hypoparathyroidism
0.015 0.985 0.000
E32.8 Other diseases of thymus
0.015 0.985 0.000
E27.2 Addisonian crisis
0.015 0.985 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.985 0.015
E27.5 Adrenomedullary hyperfunction
0.015 0.985 0.000
E27.0 Other adrenocortical overactivity
0.015 0.985 0.000
F69 Unspecified disorder of adult personality and behaviour
0.015 0.985 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.985 0.015
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.985 0.015
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.985 0.015
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.015 0.985 0.000
F43.9 Reaction to severe stress, unspecified
0.015 0.985 0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.015 0.985 0.000
C95.9 Leukaemia, unspecified
0.000 0.985 0.015
E21.0 Primary hyperparathyroidism
0.015 0.985 0.000
F80 Specific developmental disorders of speech and language
0.015 0.985 0.000
F43.0 Acute stress reaction
0.015 0.985 0.000
E27.3 Drug-induced adrenocortical insufficiency
0.015 0.985 0.000
E28.9 Ovarian dysfunction, unspecified
0.015 0.985 0.000
E28.8 Other ovarian dysfunction
0.015 0.985 0.000
E28.1 Androgen excess
0.015 0.985 0.000
E28.0 Oestrogen excess
0.015 0.985 0.000
F68 Other disorders of adult personality and behaviour
0.014 0.985 0.000
E23.7 Disorder of pituitary gland, unspecified
0.014 0.985 0.000
F42 Obsessive-compulsive disorder
0.014 0.985 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.985 0.014
E24 Cushing's syndrome
0.014 0.985 0.000
E27.9 Disorder of adrenal gland, unspecified
0.014 0.986 0.000
E22 Hyperfunction of pituitary gland
0.014 0.986 0.000
F62 Enduring personality changes, not attributable to brain damage and disease
0.014 0.986 0.000
F89 Unspecified disorder of psychological development
0.014 0.986 0.000
F88 Other disorders of psychological development
0.014 0.986 0.000
F83 Mixed specific developmental disorders
0.014 0.986 0.000
F82 Specific developmental disorder of motor function
0.014 0.986 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.014 0.986 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.986 0.014
C91.7 Other lymphoid leukaemia
0.000 0.986 0.014
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.986 0.014
C91.3 Prolymphocytic leukaemia
0.000 0.986 0.014
C91.2 Subacute lymphocytic leukaemia
0.000 0.986 0.014
F43.1 Posttraumatic stress disorder
0.014 0.986 0.000
C84.4 Peripheral T-cell lymphoma
0.000 0.986 0.014
E32.9 Disease of thymus, unspecified
0.014 0.986 0.000
E32.1 Abscess of thymus
0.014 0.986 0.000
E32.0 Persistent hyperplasia of thymus
0.014 0.986 0.000
E29 Testicular dysfunction
0.014 0.986 0.000
C88 Malignant immunoproliferative diseases
0.000 0.986 0.014
F81.9 Developmental disorder of scholastic skills, unspecified
0.014 0.986 0.000
C92.7 Other myeloid leukaemia
0.000 0.986 0.014
C92.9 Myeloid leukaemia, unspecified
0.000 0.986 0.014
E34 Other endocrine disorders
0.014 0.986 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.986 0.013
E50-E64 Other nutritional deficiencies
0.013 0.987 0.000
C93.1 Chronic monocytic leukaemia
0.000 0.987 0.013
C92.0 Acute myeloid leukaemia
0.000 0.987 0.013
E30.9 Disorder of puberty, unspecified
0.013 0.987 0.000
E30.8 Other disorders of puberty
0.013 0.987 0.000
E30.1 Precocious puberty
0.013 0.987 0.000
E30.0 Delayed puberty
0.013 0.987 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.013 0.987 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.013 0.987 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.013 0.987 0.000
E67 Other hyperalimentation
0.013 0.987 0.000
E68 Sequelae of hyperalimentation
0.013 0.987 0.000
C95.7 Other leukaemia of unspecified cell type
0.000 0.987 0.013
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.987 0.013
E31.9 Polyglandular dysfunction, unspecified
0.013 0.987 0.000
E31.8 Other polyglandular dysfunction
0.013 0.987 0.000
E31.1 Polyglandular hyperfunction
0.013 0.987 0.000
C81.9 Hodgkin's disease, unspecified
0.000 0.987 0.013
C81.0 Lymphocytic predominance
0.000 0.987 0.013
F84.5 Asperger's syndrome
0.013 0.987 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.987 0.013
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.987 0.013
E31.0 Autoimmune polyglandular failure
0.013 0.987 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.987 0.013
F44 Dissociative [conversion] disorders
0.013 0.987 0.000
C90.3 Solitary plasmacytoma
0.000 0.987 0.013
F84.0 Childhood autism
0.013 0.987 0.000
E25.9 Adrenogenital disorder, unspecified
0.012 0.987 0.000
E25.8 Other adrenogenital disorders
0.012 0.987 0.000
F43.2 Adjustment disorders
0.013 0.987 0.000
C83.5 Lymphoblastic (diffuse)
0.000 0.987 0.013
E66 Obesity
0.013 0.987 0.000
F99-F99 Unspecified mental disorder
0.012 0.987 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.987 0.012
C86.4 Blastic NK-cell lymphoma
0.000 0.987 0.012
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.987 0.012
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.987 0.012
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.987 0.012
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.987 0.012
C81.2 Mixed cellularity
0.000 0.988 0.012
F64.0 Transsexualism
0.012 0.988 0.000
C95.0 Acute leukaemia of unspecified cell type
0.000 0.988 0.012
C84.5 Other and unspecified T-cell lymphomas
0.000 0.988 0.012
F29 Unspecified nonorganic psychosis
0.012 0.988 0.000
F22 Persistent delusional disorders
0.012 0.988 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.988 0.012
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.988 0.012
C92.3 Myeloid sarcoma
0.000 0.988 0.012
C81.1 Nodular sclerosis
0.000 0.988 0.012
F43.8 Other reactions to severe stress
0.012 0.988 0.000
C83.7 Burkitt's tumour
0.000 0.988 0.012
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.988 0.012
C81.3 Lymphocytic depletion
0.000 0.988 0.012
C83.0 Small cell (diffuse)
0.000 0.988 0.012
C92.2 Subacute myeloid leukaemia
0.000 0.988 0.012
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.012 0.988 0.000
C92.4 Acute promyelocytic leukaemia
0.000 0.988 0.012
C93.9 Monocytic leukaemia, unspecified
0.000 0.988 0.012
C93.7 Other monocytic leukaemia
0.000 0.988 0.012
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.988 0.012
C93.2 Subacute monocytic leukaemia
0.000 0.988 0.012
C93.0 Acute monocytic leukaemia
0.000 0.988 0.012
F64.9 Gender identity disorder, unspecified
0.012 0.988 0.000
F64.8 Other gender identity disorders
0.012 0.988 0.000
F64.2 Gender identity disorder of childhood
0.012 0.988 0.000
F64.1 Dual-role transvestism
0.012 0.988 0.000
C92.5 Acute myelomonocytic leukaemia
0.000 0.988 0.012
F81.8 Other developmental disorders of scholastic skills
0.012 0.988 0.000
F81.3 Mixed disorder of scholastic skills
0.012 0.988 0.000
F81.2 Specific disorder of arithmetical skills
0.012 0.988 0.000
F81.1 Specific spelling disorder
0.012 0.988 0.000
F81.0 Specific reading disorder
0.012 0.988 0.000
C94.7 Other specified leukaemias
0.000 0.988 0.012
C94.5 Acute myelofibrosis
0.000 0.988 0.012
C94.3 Mast cell leukaemia
0.000 0.988 0.012
C94.2 Acute megakaryoblastic leukaemia
0.000 0.988 0.012
C94.1 Chronic erythraemia
0.000 0.988 0.012
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.988 0.012
E66.8 Other obesity
0.012 0.988 0.000
F84.9 Pervasive developmental disorder, unspecified
0.012 0.988 0.000
F84.8 Other pervasive developmental disorders
0.012 0.988 0.000
F84.4 Overactive disorder associated with mental retardation and stereotyped movements
0.012 0.988 0.000
F84.3 Other childhood disintegrative disorder
0.012 0.988 0.000
F84.2 Rett's syndrome
0.012 0.988 0.000
F84.1 Atypical autism
0.012 0.988 0.000
C94.4 Acute panmyelosis
0.000 0.988 0.012
C83.6 Undifferentiated (diffuse)
0.000 0.988 0.012
C83.4 Immunoblastic (diffuse)
0.000 0.988 0.012
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.988 0.012
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.988 0.012
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.988 0.012
C84.3 Lymphoepithelioid lymphoma
0.000 0.988 0.012
C84.2 T-zone lymphoma
0.000 0.988 0.012
C84.1 Sezary's diease
0.000 0.988 0.012
F42.9 Obsessive-compulsive disorder, unspecified
0.012 0.988 0.000
F80.1 Expressive language disorder
0.012 0.988 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.012 0.988 0.000
E45 Retarded development following protein-energy malnutrition
0.012 0.988 0.000
E43 Unspecified severe protein-energy malnutrition
0.012 0.988 0.000
E42 Marasmic kwashiorkor
0.012 0.988 0.000
E41 Nutritional marasmus
0.012 0.988 0.000
E40 Kwashiorkor
0.012 0.988 0.000
F32.9 Depressive episode, unspecified
0.012 0.988 0.000
F78 Other mental retardation
0.011 0.988 0.000
F73 Profound mental retardation
0.011 0.988 0.000
F72 Severe mental retardation
0.011 0.988 0.000
F71 Moderate mental retardation
0.011 0.988 0.000
F70 Mild mental retardation
0.011 0.988 0.000
E65 Localised adiposity
0.012 0.988 0.000
F42.0 Predominantly obsessional thoughts or ruminations
0.012 0.988 0.000
F21 Schizotypal disorder
0.012 0.988 0.000
F63.9 Habit and impulse disorder, unspecified
0.011 0.988 0.000
F63.8 Other habit and impulse disorders
0.011 0.988 0.000
F63.3 Trichotillomania
0.011 0.988 0.000
F63.2 Pathological stealing [kleptomania]
0.011 0.988 0.000
F63.1 Pathological fire-setting [pyromania]
0.011 0.988 0.000
F63.0 Pathological gambling
0.011 0.988 0.000
F65.9 Disorder of sexual preference, unspecified
0.011 0.988 0.000
F65.8 Other disorders of sexual preference
0.011 0.988 0.000
F65.6 Multiple disorders of sexual preference
0.011 0.988 0.000
F65.5 Sadomasochism
0.011 0.988 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.